Literature DB >> 6579556

Acetylcholinesterase of mammalian neuromuscular junctions: presence of tailed asymmetric acetylcholinesterase in synaptic basal lamina and sarcolemma.

P A Dreyfus, F Rieger, M Pinçon-Raymond.   

Abstract

A sarcolemma-rich fraction can be isolated after subcellular fractionation of mouse intercostal muscles by sedimentation on a discontinuous sucrose gradient. The quantitative recovery of the acetylcholine receptor in this fraction is about 50%, which indicates the presence of a high proportion of postsynaptic membranes. Acetylcholinesterase (AcChoEase; EC 3.1.1.7) is found mainly in three different layers: the top layer, which contains soluble AcChoEase, the intermediate layer (fraction A), and the last, AcChoR-rich, layer (fraction C). The relative proportions of the molecular forms of AcChoEase are different in the three layers. The "16S" AcChoEase is in a higher proportion in both types of membrane fractions (A and C) compared to soluble AcChoEase. Both total AcChoEase and 16S AcChoEase are enriched in the A and C fractions. In the C fraction, the sequential use of homogenizations in the presence of detergent and high ionic strength allows the "solubilization" of two distinct AcChoEase pools. One is detergent-soluble and mainly composed of slow-sedimenting forms; the other one is detergent-insoluble, high-ionic strength-soluble, and composed mainly of collagen-like, tailed, asymmetric (16S) AcChoEase. Thus, most of the asymmetric AcChoEase is specifically localized in the synaptic extracellular matrix of the mammalian muscle fiber. However, in the A fraction, most of the 16S AcChoEase found is solubilized by detergent alone, suggesting an association with microsomal membranes. It may mean that at least some of the basal lamina-embedded 16S AcChoEase is preassembled intracellularly in the sarcoplasmic reticulum.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6579556      PMCID: PMC391238          DOI: 10.1073/pnas.80.21.6698

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  Collagenase-induced alteration in mouse 16S acetylcholinesterase.

Authors:  F Rieger; M Ruberg; M L Shelanski
Journal:  Brain Res       Date:  1979-07-20       Impact factor: 3.252

2.  The motor end-plate specific form of acetylcholinesterase: appearance during embryogenesis and re-innervation of rat muscle.

Authors:  M Vigny; J Koenig; F Rieger
Journal:  J Neurochem       Date:  1976-12       Impact factor: 5.372

3.  Molecular structure of elongated forms of electric eel acetylcholinesterase.

Authors:  L Anglister; I Silman
Journal:  J Mol Biol       Date:  1978-11-05       Impact factor: 5.469

4.  Collagenase sensitivity and aggregation properties of Electrophorus acetylcholinesterase.

Authors:  S Bon; J Massoulié
Journal:  Eur J Biochem       Date:  1978-08-15

5.  A rapid radiochemical method for the determination of choline acetyltransferase.

Authors:  F Fonnum
Journal:  J Neurochem       Date:  1975-02       Impact factor: 5.372

6.  Molecular forms of acetylcholinesterase from Torpedo californica: their relationship to synaptic membranes.

Authors:  J S Lwebuga-Mukasa; S Lappi; P Taylor
Journal:  Biochemistry       Date:  1976-04-06       Impact factor: 3.162

Review 7.  Biochemistry and metabolism of basement membranes.

Authors:  N A Kefalides; R Alper; C C Clark
Journal:  Int Rev Cytol       Date:  1979

8.  Phospholipids in "native" Electrophorus acetylcholinesterase.

Authors:  F Rieger; S Bon; J Massoulié
Journal:  FEBS Lett       Date:  1973-10-01       Impact factor: 4.124

9.  Subcellular analysis of the molecular forms of acetylcholinesterase in rat skeletal muscle.

Authors:  J McLaughlin; W K Engel; N B Reddy
Journal:  J Neurochem       Date:  1978-10       Impact factor: 5.372

10.  Spontaneous contractile activity and the presence of the 16 S form of acetylcholinesterase in rat muscle cells in culture: reversible suppressive action of tetrodotoxin.

Authors:  F Rieger; J Koenig; M Vigny
Journal:  Dev Biol       Date:  1980-05       Impact factor: 3.582

View more
  8 in total

1.  Simultaneous labelling of basal lamina components and acetylcholinesterase at the neuromuscular junction.

Authors:  H Stephens; M Bendayan; V Gisiger
Journal:  Histochem J       Date:  1985-11

Review 2.  Molecular biological search for human genes encoding cholinesterases.

Authors:  H Soreq; A Gnatt
Journal:  Mol Neurobiol       Date:  1987 Spring-Summer       Impact factor: 5.590

3.  Proteolytic stimulation and solubilization of membrane-bound acetylcholinesterase from muscle sarcotubular system.

Authors:  F J Campoy; M D Cánovas; E Muñoz-Delgado; C J Vidal
Journal:  Neurochem Res       Date:  1989-02       Impact factor: 3.996

4.  Stabilization of collagen-tailed acetylcholinesterase in muscle cells through extracellular anchorage by transglutaminase-catalyzed cross-linking.

Authors:  D Hand; D Dias; L W Haynes
Journal:  Mol Cell Biochem       Date:  2000-01       Impact factor: 3.396

5.  Phosphatidylinositol is involved in the attachment of tailed asymmetric acetylcholinesterase to neuronal membranes.

Authors:  M Verdière-Sahuqué; L Garcia; P A Dreyfus; D Goudou; M Nicolet; F Rieger
Journal:  Cell Mol Neurobiol       Date:  1991-02       Impact factor: 5.046

6.  Tissue-specific processing and polarized compartmentalization of clone-produced cholinesterase in microinjected Xenopus oocytes.

Authors:  P A Dreyfus; S Seidman; M Pincon-Raymond; M Murawsky; F Rieger; E Schejter; H Zakut; H Soreq
Journal:  Cell Mol Neurobiol       Date:  1989-09       Impact factor: 5.046

7.  Calcium influxes and calmodulin modulate the expression and physicochemical properties of acetylcholinesterase molecular forms during development in vivo.

Authors:  L J Houenou; M V Sahuqué; A P Villageois
Journal:  Cell Mol Neurobiol       Date:  1993-06       Impact factor: 5.046

8.  Globular and asymmetric acetylcholinesterase in frog muscle basal lamina sheaths.

Authors:  M Nicolet; M Pinçon-Raymond; F Rieger
Journal:  J Cell Biol       Date:  1986-03       Impact factor: 10.539

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.